|
STXBP6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.261600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.558200E-01 |
| Normal-vs-Stage2 |
5.571800E-01 |
| Normal-vs-Stage3 |
6.791800E-02 |
| Normal-vs-Stage4 |
8.504800E-01 |
| Stage1-vs-Stage2 |
9.233000E-01 |
| Stage1-vs-Stage3 |
1.812990E-01 |
| Stage1-vs-Stage4 |
5.047200E-01 |
| Stage2-vs-Stage3 |
3.751800E-01 |
| Stage2-vs-Stage4 |
6.045000E-01 |
| Stage3-vs-Stage4 |
2.077600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.391600E-02 |
| Normal-vs-AfricanAmerican |
6.481400E-01 |
| Normal-vs-Asian |
8.611200E-01 |
| Caucasian-vs-AfricanAmerican |
5.456400E-02 |
| Caucasian-vs-Asian |
4.150000E-01 |
| AfricanAmerican-vs-Asian |
9.512400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.443500E-02 |
| Normal-vs-Female |
3.873700E-02 |
| Male-vs-Female |
9.786000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.105700E-02 |
| Normal-vs-Extreme_Weight |
1.726820E-01 |
| Normal-vs-Obese |
7.647700E-02 |
| Normal-vs-Extreme_Obese |
9.613800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.214400E-01 |
| Normal_Weight-vs-Obese |
9.369400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.742400E-01 |
| Extreme_Weight-vs-Obese |
4.924600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.217800E-01 |
| Obese-vs-Extreme_Obese |
4.062200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.387800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.216400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.215180E-01 |
| Normal-vs-Age(81-100Yrs) |
1.217040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.267800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.071800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.542400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.538000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.618800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.179000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.145700E-02 |
| Normal-VS-Type2 PRCC |
1.677150E-01 |
| Normal-VS-KIRP CIMP |
6.291400E-01 |
| Normal-VS-Unclassified PRCC |
3.895600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.889400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.506000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.193600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.259200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.068400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.735800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.425600E-01 |
| Normal-vs-N1 |
1.194960E-01 |
| Normal-vs-N2 |
8.464200E-01 |
| N0-vs-N1 |
2.682600E-01 |
| N0-vs-N2 |
8.841400E-01 |
| N1-vs-N2 |
5.614400E-01 |
|
|
